Lung cancer * 8: Management of malignant mesothelioma.
作者信息
Parker C, Neville E
机构信息
Respiratory Centre, St Mary's Hospital, Portsmouth PO3 6AD, Hants, UK.
出版信息
Thorax. 2003 Sep;58(9):809-13. doi: 10.1136/thorax.58.9.809.
Abstract
摘要
相似文献
1
Lung cancer * 8: Management of malignant mesothelioma.肺癌*8：恶性间皮瘤的管理。
Thorax. 2003 Sep;58(9):809-13. doi: 10.1136/thorax.58.9.809.
2
Therapeutic options in malignant mesothelioma.
Curr Opin Oncol. 1995 Mar;7(2):134-7. doi: 10.1097/00001622-199503000-00007.
3
Palliative care in the management of lung cancer: analgesic utilization and barriers to optimal pain management.肺癌管理中的姑息治疗：镇痛药物的使用及最佳疼痛管理的障碍
J Opioid Manag. 2012 Jan-Feb;8(1):9-16. doi: 10.5055/jom.2012.0091.
4
Malignant mesothelioma: options for management.恶性间皮瘤：治疗选择
Surg Clin North Am. 2002 Aug;82(4):797-831. doi: 10.1016/s0039-6109(02)00033-6.
5
Palliative care for the patient with mesothelioma.
Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):164-71. doi: 10.1053/j.semtcvs.2009.06.006.
6
Cardiac tamponade complicating trimodal therapy for malignant mesothelioma.
Heart Lung. 2006 Sep-Oct;35(5):355-7. doi: 10.1016/j.hrtlng.2005.10.006.
7
Chest pain and progressive miliary infiltrates in an elderly man.一名老年男性的胸痛与进行性粟粒状浸润影
Chest. 2009 Feb;135(2):578-582. doi: 10.1378/chest.07-3002.
8
Malignant pleural mesothelioma--an update.恶性胸膜间皮瘤——最新进展
Int J Occup Environ Health. 2004 Jan-Mar;10(1):26-39. doi: 10.1179/oeh.2004.10.1.26.
9
[Pleural mesothelioma. A case report].
Recenti Prog Med. 1999 Jun;90(6):327-30.
10
[Updated recommendations on systemic treatment of non-small cell lung cancer and malignant pleural mesothelioma].[非小细胞肺癌和恶性胸膜间皮瘤全身治疗的更新建议]
Pneumonol Alergol Pol. 2010;78(6):418-31.
引用本文的文献
1
Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review.恶性胸膜间皮瘤患者功能和生活质量的康复：范围综述。
Curr Oncol. 2024 Jul 30;31(8):4318-4337. doi: 10.3390/curroncol31080322.
2
Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors.恶性胸膜间皮瘤：免疫检查点抑制剂治疗患者的分期和影像学反应标准。
Target Oncol. 2024 Jan;19(1):13-28. doi: 10.1007/s11523-023-01017-w. Epub 2023 Dec 8.
3
Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors.实体瘤治疗及预后预测中T细胞增殖调节因子的综述
Heliyon. 2023 Oct 29;9(11):e21329. doi: 10.1016/j.heliyon.2023.e21329. eCollection 2023 Nov.
4
The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的治疗现状。
Curr Oncol Rep. 2022 Nov;24(11):1413-1423. doi: 10.1007/s11912-022-01302-3. Epub 2022 Jun 3.
5
Novel approaches for the treatment of unresectable malignant pleural mesothelioma: A focus on immunotherapy and target therapy (Review).治疗不可切除恶性胸膜间皮瘤的新方法：聚焦免疫治疗和靶向治疗（综述）
Mol Clin Oncol. 2022 Apr;16(4):89. doi: 10.3892/mco.2022.2522. Epub 2022 Feb 22.
6
Advanced Symptom Management System for Patients with Malignant Pleural Mesothelioma (ASyMSmeso): Mixed Methods Study.恶性胸膜间皮瘤患者高级症状管理系统（ASyMSmeso）：混合方法研究。
J Med Internet Res. 2020 Nov 12;22(11):e19180. doi: 10.2196/19180.
7
Pain management in patients with malignant mesothelioma: challenges and solutions.恶性间皮瘤患者的疼痛管理：挑战与解决方案。
Lung Cancer (Auckl). 2019 Apr 2;10:37-46. doi: 10.2147/LCTT.S192558. eCollection 2019.
8
Interventional Analgesic Management of Lung Cancer Pain.肺癌疼痛的介入性镇痛管理
Front Oncol. 2017 Feb 14;7:17. doi: 10.3389/fonc.2017.00017. eCollection 2017.
9
Clinical management of pain in advanced lung cancer.晚期肺癌的疼痛临床管理。
Clin Med Insights Oncol. 2012;6:331-46. doi: 10.4137/CMO.S8360. Epub 2012 Oct 8.
10
PET-guided dose escalation tomotherapy in malignant pleural mesothelioma.PET 引导的恶性胸膜间皮瘤调强适形放疗递增剂量。
Strahlenther Onkol. 2011 Nov;187(11):736-43. doi: 10.1007/s00066-011-2234-6. Epub 2011 Oct 28.
本文引用的文献
1
Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province.西开普省的弥漫性胸膜间皮瘤与石棉暴露
Br J Ind Med. 1960 Oct;17(4):260-71. doi: 10.1136/oem.17.4.260.
2
Management of malignant pleural effusions.恶性胸腔积液的管理
Monaldi Arch Chest Dis. 2001 Oct;56(5):394-9.
3
Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.
Semin Oncol. 2002 Feb;29(1):97-101. doi: 10.1053/sonc.2002.30235.
4
Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma.经皮影像引导下胸膜切割针活检在恶性间皮瘤诊断中的应用
Chest. 2001 Dec;120(6):1798-802. doi: 10.1378/chest.120.6.1798.
5
The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions.小口径导管胸腔造口术在治疗恶性胸腔积液中的价值。
Respiration. 2001;68(5):501-5. doi: 10.1159/000050558.
6
Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.
Lung Cancer. 2001 Nov;34(2):279-87. doi: 10.1016/s0169-5002(01)00257-4.
7
Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.可植入式胸膜导管在恶性胸腔积液所致肺陷闭综合征患者中的应用。
Chest. 2001 Jun;119(6):1641-6. doi: 10.1378/chest.119.6.1641.
8
The evolving role of antiepileptic drugs in treating neuropathic pain.抗癫痫药物在治疗神经性疼痛中不断演变的作用。
Neurology. 2000;55(5 Suppl 1):S41-6; discussion S54-8.
9
The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions.胸膜腹膜分流术在复发性恶性积液管理中的长期发病率。
Eur J Cardiothorac Surg. 2000 Aug;18(2):143-6. doi: 10.1016/s1010-7940(00)00422-x.
10
Management of malignant pleural mesothelioma: a critical review.恶性胸膜间皮瘤的管理：一项批判性综述。
Curr Opin Pulm Med. 2000 Jul;6(4):267-74. doi: 10.1097/00063198-200007000-00003.
Zotero 插件